Atlas
Back to PPM Roll-Ups
Strategic Advisor·PPM Roll-Ups

Dr. Daryl Dudum

Founder and Co-CEO at Specialty1 Partners

Novato, CA, USA (Specialty1 Partners HQ: Houston, TX)

DD
LinkedIn
Why they matter

Co-CEO who scaled a physician-led dental specialty roll-up from 8 to 200+ locations in six years, offering rare doctor-side insight into DSO joint-venture economics.

Background

Dr. Daryl Dudum, DDS, is a practicing endodontist and co-founder of Specialty1 Partners, a doctor-led dental surgical specialty partnership organization he built from six locations in 2019 into a network of 200+ practices across 27 states. He co-founded the platform as Endo1 Partners alongside Dr. Matthew Haddad and other physician partners, and has served as Co-CEO through its 2021 rebrand into a multi-specialty organization spanning endodontics, oral surgery, and periodontics. He continues to practice clinically at Marin Endodontics in Novato, CA, while running Specialty1's national growth strategy.

Notable deals

  • 2019
    Co-founded Endo1 Partners and secured a growth-equity recapitalization from VSS Capital Partners to launch the endodontic partnership platform
  • 2021
    Led reorganization of Endo1 Partners into parent company Specialty1 Partners, launching OS1 Partners (oral surgery) and Perio1 Partners (periodontics)
  • 2023
    Specialty1 Partners ranked No. 15 on the Inc. 5000 (18,747% growth 2019-2022), #1 dental company nationally for the second consecutive year
  • 2026
    Announced expanded joint-venture equity program accelerating associate-to-owner transitions for specialists across the Specialty1 network

Call-prep brief

Background

  • Practicing endodontist (DDS, University of the Pacific; Endodontics certificate, Boston University), based in Novato, CA.
  • Co-founded Endo1 Partners in 2019, growing it from 6 locations to Specialty1 Partners, now 200+ locations across 27 states and 350+ specialists.
  • Co-CEO alongside Dr. Matthew Haddad; company markets itself as doctor-founded and doctor-led.

Current Focus

  • Scaling Specialty1's joint-venture (JV) model, which converts associates into practice owners with equity stakes while preserving clinical autonomy.
  • Managing growth across three specialty verticals: Endo1 (endodontics), OS1 (oral surgery), Perio1 (periodontics).
  • Backed by growth-equity sponsors VSS Capital Partners (since 2019) and Centerbridge Partners (added as co-sponsor); secured a $525M senior secured credit facility (July 2025) to fund continued expansion.

What He Cares About

  • Preserving "doctor-led, doctor-controlled" governance — a differentiator he repeatedly emphasizes versus corporate-owned DSOs.
  • Clinical autonomy and patient-care quality alongside growth metrics.
  • Associate-to-owner pathways as a recruiting/retention lever in a tight specialist labor market.

Recent Moves

  • Feb 2026: expanded JV program highlighted via a specialist's transition to ownership (West Shore Oral Surgery).
  • Jan 2026: facilitated a multi-specialty JV combining an endodontic practice with an oral surgery practice.
  • July 2025: closed $525M senior secured credit facility (Encina Private Credit as revolver agent) to replace an outgrown bank facility.

Sensitivities

  • Still practices clinically — may be protective of the "clinical independence" narrative versus growth/margin pressure from PE sponsors.
  • Multiple institutional sponsors (VSS, Centerbridge) now involved; governance and control questions may be delicate.
  • Rapid Inc. 5000-driven growth story; likely guarded on unit economics or de novo vs. M&A mix.

Questions to Ask

  1. How is JV equity priced for associates, and what's the typical timeline to majority ownership?
  2. With Centerbridge now co-sponsoring alongside VSS, how has governance or capital allocation changed since the 2019 recapitalization?
  3. What's driving the push beyond endodontics into oral surgery and periodontics, and how do you compete for scarce specialist talent against other DSOs?

Outreach draft

Subject
Insights on Physician-Led Dental Specialty Roll-Ups
Dr. Dudum, I'm reaching out on behalf of a private equity team studying physician-led consolidation models in dental specialties. Specialty1 Partners' growth from six locations in 2019 to a 200+ location, doctor-controlled platform stands out — particularly your joint-venture approach to associate ownership. We'd value 30 minutes to hear how you've balanced clinical autonomy with institutional capital (VSS, Centerbridge) while scaling, and what you've learned structuring equity for specialists. Happy to work around your schedule — even a brief call would give us useful context for ongoing diligence in the space. Best regards, [Your Name]

Linked companies

Sources